SolutionsMarket Access
Market access analytics
Market Access
Healthcare decision-makers increasingly require evidence that extends beyond clinical trial data. Our Market Access team develops payer-focused evidence strategies that improve reimbursement and access outcomes.
What's included
- Market Access Analytics
- Deliverables
- Evidence Synthesis & NMA
Services
Market access analytics, HTA support, value dossiers, evidence synthesis and network meta-analysis.
Market Access Analytics
Payer-focused analysis and planning, from landscape assessment to HTA support.
Services
- Payer Landscape Analysis
- Reimbursement Strategy
- Market Access Planning
- Value Demonstration
- Coverage Analytics
- HTA Support
Deliverables
The evidence materials that support payer and HTA engagement.
Deliverables
- Value Dossiers
- Economic Models
- Evidence Summaries
- Submission Packages
Evidence Synthesis & NMA
Structured review and synthesis of the published evidence, including comparisons across treatments.
Services
- Systematic Literature Reviews
- Targeted Literature Reviews
- Network Meta Analysis
- Indirect Treatment Comparison
Agencies Supported
HTA support and submission packages for the agencies below.
- NICENational Institute for Health and Care ExcellenceEngland
- CADTHCanadian Agency for Drugs and Technologies in HealthCanada
- PBACPharmaceutical Benefits Advisory CommitteeAustralia
- G-BAFederal Joint Committee (Gemeinsamer Bundesausschuss)Germany
- HASHaute Autorité de SantéFrance
- ICERInstitute for Clinical and Economic ReviewUnited States
Frequently asked questions
Short answers about our Market Access work.
What is market access analytics?
Evidence and analysis that show payers and HTA bodies the value of a product, to support reimbursement and access.
What does an HTA agency evaluate?
The clinical and economic value of a health technology compared with current care, to inform pricing and reimbursement.
What is a value dossier?
A structured document that presents a product's clinical, economic and patient value evidence for payers.
Which HTA agencies do you support?
NICE, CADTH, PBAC, G-BA, HAS and ICER.
What is a network meta-analysis?
A method that compares several treatments at once by combining direct and indirect trial evidence.
Let's Build Better Evidence Together
Whether you're preparing for a product launch, generating payer evidence, executing a real-world study, supporting medical affairs, or seeking strategic market insights, Quantify Research can help.
Talk to an Expert